Skip to main content
UniHealth

Doctor search

Frank Lewis Brodie, MD

Ophthalmology · San Francisco

NPI 1811317357

Medicare standing
Clear
Enrolled, allowed to bill and order, not excluded
Plans that list them
12
2 carriers
Offices
2
Since medical school
12 years
Perelman School of Med at the University of Pennsylvania, 2014

Offices

2 locations · UCSF Medical Group Business Services · 1,533 clinicians in this group

Looking this up.

Hospitals listed: UCSF Medical Center. That is not proof they admit you there this week.

Plans that list them

12 plans · 2 carriers

A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Brodie’s office at (510) 985-5020 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.

12 of 12 plans

Plans whose provider directory lists this clinician
Alignment Health BreathEasy (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Clarity (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Harmony (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes CalPlus (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes Care (HMO C-SNP)Alignment Health PlanListedSep 28, 2026
Alignment Health Heart & Diabetes Choice (HMO C-SNP)Alignment Health PlanListedSep 28, 2026
Alignment Health Honor+ Plan (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health My Choice CalCare (HMO)Alignment Health PlanListedOct 3, 2026
Imperial Courage Plan (HMO)Imperial Health Plan of California, Inc.ListedSep 1, 2026
Imperial Dynamic Plan (HMO)Imperial Health Plan of California, Inc.ListedSep 1, 2026
Imperial Senior Value (HMO C-SNP)Imperial Health Plan of California, Inc.ListedSep 1, 2026

California Medical Board record

Licence A137610 · Current

Licensed to practise in California · since 2015 · expires 2027-01-31 · Perelman School of Medicine at the University of Pennsylvania.

Matched on the licence number without its letter prefix; check the name before relying on it.

No disciplinary actions, convictions, malpractice judgments or citations in this record.

Hospitals they work in

1 hospital

These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.

  • UCSF Medical CenterSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Other · Has an emergency department · Birthing-friendlyPart of University of California Health, which runs 12 hospitalsHome of UCSF Helen Diller Family Comprehensive Cancer Center, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 81% would definitely recommend it
    Overall rating: 4 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 4.9 (3.79 to 6.02) · 7,590 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 12.8 (11.3 to 14.4) · 2,019 cases, Jan 2024 – Dec 2024Better than the national rate — Death rate among surgical inpatients with serious treatable complications: 139.4 (110.22 to 168.58) · 452 cases, Jul 2022 – Jun 2024Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.622, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.626, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.491, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.8 (0.7 to 1) · 2,336 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for UCSF Medical Center

Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 3 better, 5 the same, 3 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at UCSF Medical Center
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths4.9 (3.79 to 6.02) · 7,590 casesWorseJul 2022 – Jun 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits12.8 (11.3 to 14.4) · 2,019 casesWorseJan 2024 – Dec 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths139.4 (110.22 to 168.58) · 452 casesBetterJul 2022 – Jun 2024
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.622BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.626BetterOct 2024 – Sep 2025
MRSA BacteremiaInfections0.491BetterOct 2024 – Sep 2025
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits0.8 (0.7 to 1) · 2,336 casesBetterJan 2024 – Dec 2024
Abdominopelvic accidental puncture or laceration rateComplications and deaths1.24 (0.58 to 1.9) · 4,689 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths1.05 (0.89 to 1.2)No differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths1.9 · 89 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths7.5 · 85 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths10.1 · 132 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths6.6 · 454 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths10.3 · 618 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths9.6 · 380 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths2.7 · 5,000 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.22 (0.06 to 0.38) · 15,965 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.2 (0.05 to 0.35) · 17,859 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths0.85 (0 to 1.83) · 4,184 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths2 (1.1 to 2.9) · 6,516 casesNo differentJul 2022 – Jun 2024
Postoperative respiratory failure rateComplications and deaths7.35 (4.49 to 10.21) · 3,989 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths5 (3.22 to 6.77) · 4,087 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.95 (0.74 to 3.15) · 2,034 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.95 (0.63 to 1.28) · 15,431 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths4 · 399 casesNoneApr 2023 – Mar 2025
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.899No differentOct 2024 – Sep 2025
SSI - Abdominal HysterectomyInfections0.689No differentOct 2024 – Sep 2025
SSI - Colon SurgeryInfections1.224No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits16 · 156 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits20 · 564 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits60.3 · 160 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-9.7 · 550 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits44.1 · 660 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits16.8 · 667 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits5.7 (4.8 to 6.7) · 2,019 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits6 · 421 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits10.5 · 53 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits20 · 107 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits13.9 (11.3 to 17.1) · 3,247 casesNo differentJan 2022 – Dec 2024

What patients said (3,181 patients answered, 25% of those asked)

Patient survey stars by topic at UCSF Medical Center
Cleanliness4
Nurse communication4
Doctor communication4
Communication about medicines3
Discharge information4
Overall hospital rating4
Quietness2
Recommend hospital5
Share of patients giving the best answer at UCSF Medical Center
Room was "always" clean71%
Nurses "always" communicated well80%
Doctors "always" communicated well80%
Staff "always" explained61%
Yes, staff "did" give patients this information88%
Yes, staff "did" give patients information about help after discharge87%
Doctors "always" explained things so they could understand74%
Doctors "always" listened carefully78%
Doctors "always" treated them with courtesy and respect86%
Patients who gave a rating of "9" or "10" (high)76%
Staff "always" explained new medications75%
Nurses "always" explained things so they could understand77%
Nurses "always" listened carefully78%
Nurses "always" treated them with courtesy and respect86%
"Always" quiet at night50%
"YES", patients would definitely recommend the hospital81%
Staff "always" explained possible side effects46%
Yes, staff "did" give patients information about possible symptoms90%

Original Medicare doctor bills

$45,126

Medicare paid this office $45,126 for 133 people.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Largest Original Medicare bills
Injection of drug into eye37$11,124$96
Established patient complete exam of visual system71$6,666$68
Imaging of retina97$4,623$23
Injection of drug into eye33$4,589$68
Established patient complete exam of visual system45$2,574$50
See all 6 services
Every Original Medicare service billed
Injection of drug into eye37$11,124$96
Established patient complete exam of visual system71$6,666$68
Imaging of retina97$4,623$23
Injection of drug into eye33$4,589$68
Established patient complete exam of visual system45$2,574$50
Imaging of retina66$1,765$16

Procedures year by year

Procedures billed to Original Medicare by year
Procedure201920202021202220232024
Injection of drug into eye––30116174183
Removal of eye fluid (vitreous) between lens and retina–11––––

Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.

Who their Medicare patients are

133 Original Medicare patients in 2024. Average age 76 · Women 56% · Also on Medicaid 32% · Health risk score 1.59. Sicker patients than 9 in 10 peers; the typical ophthalmology clinician is at 1.16.

Conditions among them: High blood pressure 68% · Diabetes 35% · Chronic kidney disease 29% · Coronary heart disease 24% · Depression 22% · Cancer 20% · Atrial fibrillation 19% · Heart failure 17% · Stroke 8%.

The office billed $481,566, Medicare allowed $61,845 and paid $45,126; for 709 services of 24 kinds.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Original Medicare by year
2024133709761.59$481,566$45,126
2023178923751.70$609,658$60,309
2022162847751.48$559,232$59,312
2021115365721.43$171,932$20,019
202060100701.75$56,298$8,087
20195171691.56$49,673$8,138

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

See the services billed each year

2023: 4 services

Original Medicare services billed in 2023
Established patient complete exam of visual system149$14,748$63
Injection of drug into eye43$12,526$72
Imaging of retina162$8,618$21
New patient complete exam of visual system16$1,290$81

2022: 7 services

Original Medicare services billed in 2022
Established patient complete exam of visual system110$11,714$68
Injection of drug into eye36$9,249$80
Imaging of retina157$8,209$22
New patient complete exam of visual system38$3,211$84
Short return visit (20+ min)11$654$59
Established patient problem focused exam of visual system16$651$36
Extended exam of the back part of the eye with retinal drawing20$354$18

2021: 6 services

Original Medicare services billed in 2021
New patient complete exam of visual system34$2,984$88
Imaging of retina85$2,937$25
Injection of drug into eye16$2,626$88
Established patient complete exam of visual system19$1,435$76
Established patient problem focused exam of visual system18$1,024$47
Extended exam of the back part of the eye with retinal drawing30$689$22

2020: 3 services

Original Medicare services billed in 2020
Removal of eye fluid (vitreous) between lens and retina11$1,229$112
Established patient problem focused exam of visual system13$768$55
Imaging of retina18$504$28

2019: 1 service

Original Medicare services billed in 2019
Imaging of retina15$467$31

Medicaid work

$8,739 in 2024

Medicaid paid $8,739 for 78 billed services this clinician did in 2024, up to 19 people in a month for one service.

Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.

Largest Medicaid services in 2024
Intravitreal injection of a pharmacologic agent (separate procedure)15$6,483
Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina49$1,324
OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST14$932
Medicaid work by year
202478319$8,739
2023235221$10,256
202292121$2,014
202115115$347
See the largest Medicaid services in earlier years

2023

Largest Medicaid services in 2023
OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST80$6,170
Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina155$4,085

2022

Largest Medicaid services in 2022
Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina92$2,014

2021

Largest Medicaid services in 2021
Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina15$347

Drugs they prescribed that Part D paid

$8,060

Pharmacies billed $8,060 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

Opioids were 0% of their Part D prescriptions (0 of 131) in 2024. At or below the middle of the specialty; the typical ophthalmology clinician is at 0%.

93 generic and 38 brand-name prescriptions · $8,060 in drug cost.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Largest Part D drug costs
Prednisolone Acetate19$1,262$66
Brimonidine11$617$56
Atropine Sulfate12$413$34
Ketorolac Tromethamine16$318$20
Dorzolamide-Timolol16$160$10
See all 6 drugs
Every Part D drug this clinician prescribed
Prednisolone Acetate19$1,262$66
Brimonidine11$617$56
Atropine Sulfate12$413$34
Ketorolac Tromethamine16$318$20
Dorzolamide-Timolol16$160$10
Latanoprost13$117$9

Year by year

Part D prescribing by year
2024131340% (0)29%$8,060
2023164430% (0)38%$11,597
202217454None30%$9,309
20215711750% (0)43%$40,150
20206051970% (0)40%$57,228
201925096None42%$11,852
201869180% (0)29%$4,409
2017195640% (0)41%$13,585
2016193360% (0)48%$13,782
201516None0% (0)None$1,192

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2023: 6 drugs

Part D drugs prescribed in 2023
Prednisolone Acetate30$1,772$59
Atropine Sulfate16$1,096$68
Ketorolac Tromethamine20$846$42
Dorzolamide-Timolol18$419$23
Brimonidine13$209$16
Latanoprost16$202$13

2022: 6 drugs

Part D drugs prescribed in 2022
Prednisolone Acetate34$2,344$69
Atropine Sulfate23$1,782$77
Timolol Maleate13$1,278$98
Dorzolamide-Timolol24$553$23
Polymyxin B Sul-Trimethoprim17$139$8
Brimonidine13$128$10

2021: 12 drugs

Part D drugs prescribed in 2021
Durezol31$7,951$256
Prednisolone Acetate115$6,148$53
Atropine Sulfate52$3,048$59
Ketorolac Tromethamine55$2,367$43
Brimonidine23$1,661$72
Dorzolamide-Timolol55$1,130$21
Valacyclovir11$983$89
Ofloxacin38$811$21
Erythromycin45$536$12
Dorzolamide16$423$26
Latanoprost21$321$15
Timolol Maleate25$264$11

2020: 12 drugs

Part D drugs prescribed in 2020
Prednisolone Acetate116$6,237$54
Ketorolac Tromethamine107$4,590$43
Atropine Sulfate41$2,290$56
Brimonidine18$2,144$119
Dorzolamide-Timolol34$1,580$46
Ofloxacin36$817$23
Erythromycin41$525$13
Dorzolamide12$361$30
Timolol Maleate20$350$17
Latanoprost17$170$10
Gentamicin Sulfate13$147$11
Prednisone20$121$6

2019: 5 drugs

Part D drugs prescribed in 2019
Prednisolone Acetate59$2,371$40
Atropine Sulfate27$1,453$54
Ofloxacin42$1,273$30
Erythromycin44$496$11
Ketorolac Tromethamine12$433$36

2018: 2 drugs

Part D drugs prescribed in 2018
Brimonidine17$2,130$125
Timolol Maleate19$222$12

2017: 6 drugs

Part D drugs prescribed in 2017
Alphagan P11$3,139$285
Brimonidine20$1,497$75
Prednisolone Acetate27$1,458$54
Latanoprost39$826$21
Timolol Maleate39$452$12
Dorzolamide16$340$21

2016: 5 drugs

Part D drugs prescribed in 2016
Brimonidine46$3,579$78
Travatan Z14$2,727$195
Dorzolamide35$795$23
Latanoprost28$491$18
Timolol Maleate20$170$9

Money from drug and device companies

$13,164 in 2025

Industry payments by year
20251231$11,750$13,164
20241442$16,966$19,324
2023931$10,450$13,908
2022510None$356
202147None$695
202055$350$613
2019614None$2,588

Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.

A payment is not proof that care is biased.

Payments by company
F. Hoffmann-La Roche AGNone$4,810
4 payments
  • Consulting · 2025-12-04 · $2,925
  • Meals · 2025-12-04 · $27
  • Meals · 2025-05-05 · $58
  • Consulting · 2025-05-05 · $1,800
Genentech USASusvimo$4,218
8 payments
  • Meals for Vabysmo · 2025-09-23 · $33
  • Meals for Susvimo · 2025-07-30 · $33
  • Meals for Vabysmo · 2025-06-04 · $27
  • Consulting for Susvimo · 2025-04-25 · $2,925
  • Meals for Susvimo · 2025-03-27 · $25
  • Meals for Vabysmo · 2025-03-13 · $26
  • Consulting for Susvimo · 2025-01-09 · $575
  • Consulting for Susvimo · 2025-01-09 · $575
Tarsus PharmaceuticalsNone$2,380
2 payments
  • Consulting · 2025-06-23 · $2,375
  • Meals · 2025-04-03 · $5
GenentechSusvimo$575
1 payment
  • Consulting for Susvimo · 2025-04-08 · $575
Alcon VisionConstellation$331
5 payments
  • Meals for Unity · 2025-09-06 · $64
  • Meals for Constellation · 2025-07-30 · $162
  • Meals for Unity · 2025-06-14 · $26
  • Meals for Unity · 2025-06-14 · $43
  • Meals for Constellation · 2025-01-15 · $36
Alcon ResearchNone$300
1 payment
  • Meals · 2025-10-17 · $300
See all 31 published payments
Every published payment
F. Hoffmann-La Roche AGConsulting · 2025-12-04None$2,925
F. Hoffmann-La Roche AGMeals · 2025-12-04None$27
AbbvieMeals · 2025-12-03Ozurdex$37
Alcon ResearchMeals · 2025-10-17None$300
Genentech USAMeals · 2025-09-23Vabysmo$33
Alcon VisionMeals · 2025-09-06Unity$64
Astellas Pharma USMeals · 2025-08-21Izervay$27
Astellas Pharma USMeals · 2025-08-01Izervay$75
Dutch Ophthalmic USAMeals · 2025-07-31Eva, Combined Machine$149
Alcon VisionMeals · 2025-07-30Constellation$162
Genentech USAMeals · 2025-07-30Susvimo$33
ANI PharmaceuticalsMeals · 2025-07-11Yutiq$32
Regeneron Healthcare SolutionsMeals · 2025-07-10Eylea Hd$26
Astellas Pharma USMeals · 2025-06-26Izervay$101
Tarsus PharmaceuticalsConsulting · 2025-06-23None$2,375
Alcon VisionMeals · 2025-06-14Unity$26
Alcon VisionMeals · 2025-06-14Unity$43
Genentech USAMeals · 2025-06-04Vabysmo$27
AbbvieMeals · 2025-05-28Ozurdex$24
F. Hoffmann-La Roche AGMeals · 2025-05-05None$58
F. Hoffmann-La Roche AGConsulting · 2025-05-05None$1,800
Genentech USAConsulting · 2025-04-25Susvimo$2,925
GenentechConsulting · 2025-04-08Susvimo$575
Tarsus PharmaceuticalsMeals · 2025-04-03None$5
Genentech USAMeals · 2025-03-27Susvimo$25
Regeneron Healthcare SolutionsMeals · 2025-03-17Eylea Hd$25
Genentech USAMeals · 2025-03-13Vabysmo$26
Bausch & Lomb AmericasMeals · 2025-03-11Xipere$54
Alcon VisionMeals · 2025-01-15Constellation$36
Genentech USAConsulting · 2025-01-09Susvimo$575
Genentech USAConsulting · 2025-01-09Susvimo$575
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)

2024: $19,324

Payments by company in 2024
AbbvieOzurdex$6,574
6 payments
  • Meals for Ozurdex · 2024-10-24 · $95
  • Meals for Ozurdex · 2024-08-20 · $27
  • Education · 2024-05-05 · $8
  • Meals · 2024-05-01 · $30
  • Meals for Ozurdex · 2024-05-01 · $13
  • Consulting for Ozurdex · 2024-01-03 · $6,400
Tarsus PharmaceuticalsNone$4,750
2 payments
  • Consulting · 2024-11-20 · $1,900
  • Consulting · 2024-11-20 · $2,850
Genentech USASusvimo$2,990
10 payments
  • Meals for Vabysmo · 2024-11-09 · $30
  • Meals for Susvimo · 2024-09-06 · $23
  • Meals for Susvimo · 2024-09-06 · $4
  • Consulting · 2024-08-17 · $2,290
  • Consulting for Susvimo · 2024-08-09 · $575
  • Meals for Susvimo · 2024-08-09 · $7
  • Meals for Susvimo · 2024-08-09 · $19
  • Meals for Vabysmo · 2024-08-02 · $4
  • Meals for Vabysmo · 2024-08-02 · $19
  • Meals for Vabysmo · 2024-03-26 · $19
Apellis PharmaceuticalsSyfovre$1,994
3 payments
  • Meals for Syfovre · 2024-10-19 · $190
  • Honoraria · 2024-10-19 · $1,701
  • Meals for Syfovre · 2024-06-28 · $103
Bausch & Lomb AmericasMiebo$1,490
4 payments
  • Paid to speak or teach for Miebo · 2024-12-04 · $1,250
  • Meals for Xipere · 2024-11-23 · $164
  • Meals for Xipere · 2024-06-04 · $35
  • Meals for Xipere · 2024-04-12 · $41
Alcon VisionConstellation$517
4 payments
  • Meals for Constellation · 2024-09-25 · $139
  • Meals for Constellation · 2024-09-11 · $143
  • Meals for Constellation · 2024-07-17 · $135
  • Meals for Constellation · 2024-06-08 · $100
Harrow EyeIheezo$349
3 payments
  • Meals for Iheezo · 2024-10-19 · $117
  • Meals for Triesence · 2024-10-19 · $117
  • Meals · 2024-10-19 · $115
GenentechVabysmo$190
2 payments
  • Meals for Susvimo · 2024-06-05 · $40
  • Meals for Vabysmo · 2024-05-06 · $149
Carl Zeiss MeditecVeracity Surgical$168
1 payment
  • Meals for Veracity Surgical · 2024-10-19 · $168
Dutch Ophthalmic USAEva, Combined Machine$166
1 payment
  • Meals for Eva, Combined Machine · 2024-08-29 · $166
Regeneron PharmaceuticalsEylea Hd$49
2 payments
  • Meals for Eylea Hd · 2024-09-20 · $30
  • Meals for Eylea Hd · 2024-08-17 · $20
Astellas Pharma USIzervay$33
1 payment
  • Meals for Izervay · 2024-03-08 · $33
Regeneron Healthcare SolutionsEylea Hd$28
2 payments
  • Meals for Eylea Hd · 2024-06-13 · $13
  • Meals for Eylea Hd · 2024-02-20 · $15
Alimera SciencesYutiq$27
1 payment
  • Meals for Yutiq · 2024-06-07 · $27

2023: $13,908

Payments by company in 2023
Genentech USAVabysmo$10,096
8 payments
  • Travel for Vabysmo · 2023-04-22 · $201
  • Consulting for Vabysmo · 2023-04-22 · $5,990
  • Meals for Vabysmo · 2023-04-22 · $112
  • Travel for Vabysmo · 2023-04-22 · $897
  • Travel for Vabysmo · 2023-04-22 · $442
  • Meals for Vabysmo · 2023-04-22 · $318
  • Consulting for Susvimo · 2023-03-15 · $2,115
  • Meals for Vabysmo · 2023-03-01 · $21
GenentechSusvimo$2,509
3 payments
  • Consulting for Susvimo · 2023-12-06 · $2,345
  • Meals for Vabysmo · 2023-06-06 · $22
  • Meals for Vabysmo · 2023-04-21 · $142
Dutch Ophthalmic USAEva, Combined Machine$568
4 payments
  • Meals for Eva, Combined Machine · 2023-07-30 · $176
  • Meals for Eva, Combined Machine · 2023-07-28 · $176
  • Meals for Eva, Combined Machine · 2023-05-12 · $151
  • Meals for Eva, Combined Machine · 2023-03-13 · $66
Bausch & Lomb AmericasXipere$275
5 payments
  • Meals for Xipere · 2023-12-27 · $28
  • Meals for Stellaris · 2023-11-29 · $52
  • Meals for Xipere · 2023-08-28 · $25
  • Meals for Xipere · 2023-07-31 · $148
  • Meals for Xipere · 2023-06-19 · $21
AbbVieOzurdex$224
3 payments
  • Travel for Ozurdex · 2023-11-30 · $133
  • Travel for Ozurdex · 2023-11-30 · $72
  • Meals for Ozurdex · 2023-09-29 · $18
Alimera SciencesYutiq$102
3 payments
  • Meals for Yutiq · 2023-11-09 · $51
  • Meals for Yutiq · 2023-11-04 · $24
  • Meals for Iluvien · 2023-05-05 · $27
Regeneron Healthcare SolutionsEylea Hd$58
2 payments
  • Meals for Eylea Hd · 2023-10-26 · $34
  • Meals for Eylea · 2023-06-01 · $24
Astellas Pharma USNone$56
2 payments
  • Meals · 2023-10-14 · $32
  • Meals · 2023-10-03 · $25
Regeneron PharmaceuticalsEylea Hd$20
1 payment
  • Meals for Eylea Hd · 2023-08-26 · $20

2022: $356

Payments by company in 2022
Regeneron Healthcare SolutionsEylea$116
1 payment
  • Meals for Eylea · 2022-12-14 · $116
Genentech USASusvimo$90
4 payments
  • Meals for Susvimo · 2022-09-23 · $23
  • Meals for Susvimo · 2022-08-16 · $24
  • Meals for Vabysmo · 2022-08-11 · $22
  • Meals for Vabysmo · 2022-03-20 · $20
GenentechSusvimo$85
2 payments
  • Meals for Susvimo · 2022-10-12 · $61
  • Meals for Susvimo · 2022-08-09 · $24
Alcon VisionConstellation$43
2 payments
  • Meals for Constellation · 2022-12-20 · $16
  • Meals for Constellation · 2022-11-08 · $27
Alimera SciencesIluvien$22
1 payment
  • Meals for Iluvien · 2022-04-22 · $22

2021: $695

Payments by company in 2021
Alcon VisionAcrysof Iq Panoptix$460
4 payments
  • Meals for Acrysof Iq Panoptix · 2021-06-09 · $187
  • Meals for Ngenuity · 2021-04-26 · $146
  • Meals for Constellation · 2021-04-26 · $33
  • Meals for Constellation · 2021-03-18 · $95
GenentechNone$116
1 payment
  • Meals · 2021-07-13 · $116
Regeneron Healthcare SolutionsEylea$102
1 payment
  • Meals for Eylea · 2021-06-04 · $102
Genentech USASusvimo$16
1 payment
  • Meals for Susvimo · 2021-11-04 · $16

2020: $613

Payments by company in 2020
Alimera SciencesIluvien$350
1 payment
  • Honoraria for Iluvien · 2020-05-02 · $350
GenentechLucentis$91
1 payment
  • Meals for Lucentis · 2020-02-11 · $91
Bausch & Lomb a division of Bausch Health USStellaris PC$91
1 payment
  • Meals for Stellaris PC · 2020-02-24 · $91
Alcon VisionConstellation$55
1 payment
  • Meals for Constellation · 2020-08-11 · $55
Ocular TherapeutixDextenza$27
1 payment
  • Meals for Dextenza · 2020-07-07 · $27

2019: $2,588

Payments by company in 2019
Alcon VisionDailies$1,456
7 payments
  • Meals · 2019-11-22 · $239
  • Travel · 2019-11-22 · $194
  • Travel · 2019-11-22 · $80
  • Travel for Dailies · 2019-11-22 · $331
  • Meals for Luxor · 2019-10-25 · $113
  • Meals for Constellation · 2019-08-29 · $65
  • Meals · 2019-05-19 · $434
Regeneron PharmaceuticalsNone$806
2 payments
  • Travel · 2019-04-13 · $400
  • Travel · 2019-04-13 · $406
Carl Zeiss MeditecArtevo 800$142
1 payment
  • Meals for Artevo 800 · 2019-11-08 · $142
EyePoint Pharmaceuticals USDexycu$90
2 payments
  • Meals for Dexycu · 2019-08-30 · $15
  • Meals for Dexycu · 2019-08-29 · $75
Genentech USALucentis$70
1 payment
  • Meals for Lucentis · 2019-07-31 · $70
Bausch & Lomb a division of Bausch Health USStellaris PC$24
1 payment
  • Meals for Stellaris PC · 2019-06-26 · $24

Research money

Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.

Research payments by company and study
F. Hoffmann-La Roche AG · Economic Benefit of Faricimab Compared To Aflibercept 8mg in Treating Patients With Neovascular Age-Related Macular Degeneration Or Diabetic Macular Edema in the United States · 2024This clinician$3,047
F. Hoffmann-La Roche AG · Population Impact Model of Faricimab and Aflibercept 8mg Among US Patients With Diabetic Macular Edema and Neovascular Age-Related Macular Degeneration · 2025This clinician$1,553
F. Hoffmann-La Roche AG · Pigment Epithelial Detachment Thickness Fluctuations in the Archway Trial of the Port Delivery System With Ranibizumab · 2025This clinician$698

Checkups this office reported

Medicare did not publish checkup rates for this clinician.

Medicare’s overall office score
91.9 / 100
Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.

Professional record

NPI
1811317357
Licence
CA 137610California A137610: Current · expires 2027-01-31
Trained
Perelman School of Med at the University of Pennsylvania, 2014 · 12 years ago
Gender
Male
More record details
Sole proprietor
No
Taxonomy
Federal specialty code 207W00000X (207W00000X); Student in a training program (390200000X)
Mailing address
10 Koret Way, Suite K302, San Francisco, CA, 94143
NPI first listed
2014-04-23
NPI last updated
2015-11-24

This is when the NPI record was last certified, not a medical board exam.